351. Fungal endocarditis after transcatheter aortic valve replacement (TAVR): Case report and review of literature.
- Author
-
Morioka H, Tokuda Y, Oshima H, Iguchi M, Tomita Y, Usui A, and Yagi T
- Subjects
- Aged, 80 and over, Antifungal Agents therapeutic use, Candida parapsilosis, Humans, Male, Reoperation, Candidiasis, Invasive diagnosis, Candidiasis, Invasive drug therapy, Candidiasis, Invasive etiology, Candidiasis, Invasive surgery, Endocarditis diagnosis, Endocarditis drug therapy, Endocarditis etiology, Endocarditis surgery, Transcatheter Aortic Valve Replacement adverse effects
- Abstract
The reported number of transcatheter aortic valve replacement-associated infective endocarditis (TAVR-IE) cases has been increasing worldwide, but information about the incidence and clinical features of fungal TAVR-IE is quite limited. We present a patient who acquired TAVR-IE caused by Candida parapsilosis four month after TAVR, who was successfully treated redo-aortic valve replacement and prolonged antifungal therapy., (Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF